[1] Société de pathologie infectieuse de langue française. Antibiothérapiedes infections urinaires. Med Mal Infect. 1991;21:51–4.
[2] Drouin P, Blickle JF, Charbonnel B, et al. DIAGNOSTIC ET
CLASSIFICATION DU DIABETE SUCRE´ LES NOUVEAUX CRITERES. 2018; 25: 12.
[3] Maroc:1 diabétique sur 2 ignore sa maladie | L’Economiste,
https://www.leconomiste.com/flash-infos/maroc-1-diabetique-sur-2-ignore-sa-maladie (accessed 21 February 2020).
[4] https://www.senat.fr/rap/r10-158/r10-158_mono.html.
[5] Reine JL. Médecine Nucléaire Imagerie fonctionnelle et métabolique 2001
-vol.25 -n°2,
https://www.academia.edu/9824666/M%C3%A9decine_Nucl%C3%A9aire_-Imagerie_fonctionnelle_et_m%C3%A9tabolique_-2001_-vol.25_-n_2
(accessed 17 February 2020).
[6] Ahlqvist E, Storm P, Käräjämäki A et al. Novel subgroups of adult-onset
diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018 May;6(5):361-369.
92
[9] Yeung W-CG, Rawlinson WD, Craig ME. Enterovirus infection and type 1
diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35.
[10] Mariño E, Richards JL, McLeod KH, et al. Gut microbial metabolites limit
the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol 2017;18:552–62.
[11] Needell JC, Ir D, Robertson CE, et al. Maternal treatment with shortchain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring. PloS One 2017;12:e0183786.
[12] Hänninen A, Toivonen R, Pöysti S, et al. Akkermansia muciniphila induces
gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut 2017.
[13] Niinistö S, Takkinen H-M, Uusitalo L, et al. Maternal intake of fatty acids
and their food sources during lactation and the risk of preclinical and clinical type 1 diabetes in the offspring. Acta Diabetol 2015; 52:763-72.
[14] Bonifacio E, Warncke K, Winkler C, et al. Cesarean section and
interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 2011;60:3300-6.
[15] Revue Francophone Des Laboratoires • N° 502 • MAI 2018.
[16] Bergholdt R, Brorsson C, Palleja A, et al. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012;61:954-62.
[18] Zheng W, She J-X. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 2005;54:906-8.
[19] Flanagan SE, Haapaniemi E, Russell MA, et al. Activating germline
mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 2014;46:812-4.
[20] Størling J, Pociot F. Type 1 Diabetes Candidate Genes Linked to Pancreatic
Islet Cell Inflammation and Beta-Cell Apoptosis. Genes 2017;8.
[21] Berchtold LA, Størling ZM, Ortis F, et al. Huntingtin-interacting protein 14
is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc Natl Acad Sci U S A 2011;108:E681-8.
[22] Juan-Mateu J, Alvelos MI, Turatsinze J-V, et al. SRp55 Regulates a
Splicing Network that Controls Human Pancreatic Beta Cell Function and Survival. Diabetes 2017.
[23] Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-10.
[24] Accili D, Talchai SC, Kim-Muller JY, et al. When -cells fail: lessons from
dedifferentiation. Diabetes Obes Metab 2016;18 Suppl 1:117–22.
[25] Karaca M, Magnan C, Kargar C. Functional pancreatic beta-cell mass:
94
[27] Ndiaye FK, Ortalli A, Canouil M, et al. Expression and functional
assessment of candidate type 2 diabetes susceptibility genes identify four new genes contributing to human insulin secretion. Mol Metab 2017;6:459-70. [28] Hernández EÁ, Kahl S, Seelig A, et al. Acute dietary fat intake initiates
alterations in energy metabolism and insulin resistance. J Clin Invest 2017;127:695-708.
[29] Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J
Clin Invest 2017;127:14-23.
[30] Lee YS, Wollam J, Olefsky JM. An Integrated View of Immunometabolism.
Cell 2018;172:22-40.
[31] Ferdaoussi M, Abdelli S, Yang J-Y, et al. Exendin-4 protects betacells from
interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 2008;57:1205-15.
[32] Sato J, Kanazawa A, Watada H. Type 2 Diabetes and Bacteremia. Ann Nutr
Metab 2017;71 Suppl 1:17-22.
[33] Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota
from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-6.e7.
[34] Plaisance V, Brajkovic S, Tenenbaum M, et al. Endoplasmic Reticulum
Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL. PloS One 2016;11:e0163046.
[35] Dayeh T, Ling C. Does epigenetic dysregulation of pancreatic islets
contribute to impaired insulin secretion and type 2 diabetes? Biochem Cell Biol Biochim Biol Cell 2015;93:511-21.
[36] Bellamy L, Casas J-P, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet 2009;373:1773-9.
[37] Schaefer-Graf U, Napoli A, Nolan CJ, Diabetic Pregnancy Study Group.
Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia 2018.
[38] Baeyens L, Hindi S, Sorenson RL, et al. -Cell adaptation in pregnancy.
Diabetes Obes Metab 2016;18 Suppl 1:63-70.
[39] Kenna LA, Olsen JA, Spelios MG, et al. -Cell death is decreased in women
with gestational diabetes mellitus. Diabetol Metab Syndr 2016;8:60.
[40] Lowe WL, Scholtens DM, Sandler V, et al. Genetics of Gestational Diabetes
Mellitus and Maternal Metabolism. Curr Diab Rep 2016;16:15.
[41] Zheng J, Xiao X, Zhang Q, et al. The Placental Microbiota Is Altered among
Subjects with Gestational Diabetes Mellitus: A Pilot Study. Front Physiol 2017;8:675.
[42] Mokkala K, Houttu N, Vahlberg T, et al. Gut microbiota aberrations
precede diagnosis of gestational diabetes mellitus. Acta Diabetol 2017;54:1147-9.
[43] B. VANDELEENE. Les complications aiguës du diabète. Louvain Med. 119:
96
[46] Grimaldi A., Slama G., Tubiana-Rufi N., Heurtier A., Selam J. L., Scheen
A., Sachon C., Vialettes B., Robert J.J., Perlemuter L. L’hypoglycémie du patient diabétique, Diabetes & metabolism, 1997, vol. 23, no1, pp. 100-108 (34 ref.).
[47] D. Raccah. Épidémiologie et physiopathologie des complications
dégénératives du diabète sucré. Encyclopédie Médico-Chirurgicale
Endocrinologie-Nutrition 10-366-I10 (2004).
[48] A. Grimaldi, S. JACQUEMINET. Guide pratique du diabète. Elsevier
Masson, 2005.
[49] L. Perlemuter, J.-L. Selam, G. Collin De L’hortet. Diabète et maladies
métaboliques. Elsevier Masson, 2003.
[50] GIN H ET RIGALLEAU V. Diététique et diabètes. Encycl Méd Chir
(Elsevier, Paris), Endocrinologie-Nutrition, 10-366-R-10, 1999, 6 .
[51] H HANAIRE-BROUTIN. Insulinothérapie et autosurveillance glycémique :
schéma thérapeutique et recommandations. Diabetes & Metabolism Vol 29, N° 2-C2 - avril 2003 pp. 21-25.
[52] Tournant F, Heurtier A, Bosquet F, GRIMALDI A. Classification du
diabète sucré. Critères diagnostiques et dépistage. Encycl Méd Chir (Elsevier, Paris), Endocrinologie-Nutrition, 10-366-A-10, 1998, 13 .
[53] S Halimi, G Rostoker, Jj Altman, C Attali, J Beaune, C Belorgey-Bismut, Am Bouldouyre-Magnier, D Cordonnier, C Denis, L Duranteau, A Grimaldi, Pj Guillausseau, F Koenig, G Lagrue, L Monnier, J Orgiazzi, M Raucoules-Aimé, H Saltiel, D Simon, M Varroud-Vial. Traitement médicamenteux du diabète de type 2. Diabetes & Metabolism Vol 25, N° 6 - novembre 1999 . 533.
[54] B. Charbonnel, B. Bouhanick, C. Le Feuvre, B. Bauduceau, N. Danchin, Jf. Gautier, A. Grimaldi, P. Henry, F. Paillard, D. Pallo, C. Piot, P. Sabouret. Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue. Diabetes & Metabolism Vol 30, N° 2-C2 - avril 2004 . 3.
[55] Stratégie de prise en charge du patient diabétique de type 2 à l’exclusion de la
prise en charge des complications. Diabetes & Metabolism Vol 26, N° SUP 5 - septembre 2000 . 10.
[56] P. Drouin, J.F. Blickle, B. Charbonnel, E. Eschwege, P.J. Guillausseau,
P.F. Plouin, J.M. Daninos, N. Balarac, J.P. Sauvanet. Diagnostic et classification du diabète sucré - Les nouveaux critères, Rapport des experts de l’ALFEDIAM. Diabetes & Metabolism (Paris) 1999, 25, 72-83.
[57] Blickle Jf. Traitements oraux du diabète. Encycl Méd Chir (Elsevier, Paris), Endocrinologie-Nutrition, 10-366-R-20, 1999, 14 .
[58] Blickle Jf. Actualités sur les traitements oraux du diabète. Encycl Méd Chir (Elsevier SAS, Paris), Endocrinologie-Nutrition, 10-366-R-25, 2002, 5 .
[59] F. Bosquet, A. Hartemann-Heurtier. Insulinothérapie dans le diabète de
type 2. Encyclopédie Médico-Chirurgicale Endocrinologie-Nutrition 10-366-R-30 (2004).
98
[62] Afssaps: Agence Francaise De Securite Sanitaire Des Produits De Sante,
Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires du nourrisson et de l’enfant, Février 2007.
[63] Rutreau-Lemairem, Botto H.: Infections urinaires nosocomiales. Prog urol,
vol : 7, n°:4, 1997, 674 -682.
[64] Loudyi T.: Les infections urinaires en milieu intra et extra hospitalier de rabat. Bilan de 2 années. Thèse (pharmacie), n° :5, 1997, Faculté de médecine et de pharmacie, Rabat.
[65] Mazzulli T, Skulnick M, Small G et coll. Susceptibility of community
Gram-negative urinary tract isolates to mecillinam and other oral agents. Can JInfect Dis 2001;12:289-292.
[66] Kunin CM. Urinary tract infections in females. Clin Infect Dis
1994;18(1):1-10.
[67] To T, Agha M, Dick PT, Feldman W. Cohort study on circumcision of
new-born boys and subsequent risk of urinary-tract infection.
Lancet1998;352:1813-1816.
[68] Nicolle LE. Resistant pathogens in urinary tract infections. J Am Geriatr Soc2002;50(7 Suppl):S230-235.
[69] Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and
economic costs. American Journal of Medicine 2002; 113:5S-13S.
[70] Caron F.: Physiopathologie des infections urinaires nosocomiales ; Méd Mal
infect ; 2003.
[71] Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract
[72] Meyrier A.; Affre.J.; Bensman A.; Duclos J.M.; Moulonguet-Doleris L.; Ronco E. ; Ronco P: Les infections de l’appareil urinaire, Chapitre 12 : la pyélonéphrite aiguë, 149- 150.
[73] Blery M.; Blery-Krssat M.; Hammoudi Y.; Rocher L.: Pathologie
infectieuse du haut appareil urinaire. EMC (Elsevier Masson SAS, Paris), Radiodiagnostic-Urologie- Gynécologie, 34-150-A-10, 2006.
[74] Meyrier A.; Affre J.; Bensman A.; Duclos J.M. ; Moulonguet-Doleris L.;
Ronco E.; Ronco P.: Les infections de l’appareil urinaire. Chapitre 2: Bactériologie, 37 ,39 ,40 ,41 ,42 ,44 ,45.
[75] Meyrier A.; Affre.J; Bensman A.; Duclos J.M.; Moulonguet-Doleris L.;
Ronco E.; Ronco P: Les infections de l’appareil urinaire. Chapitre 7 : Infection de l’appareil urinaire chez la femme, 106,107,108.
[76] Beaucaire G.; Mouton Y.: Infection à E.coli. Encyclo. Méd. Chir. Paris
Thérapeutique, 1981.
[77] Archambaud M.: Adhérence bactérienne : Facteurs de virulence dans les
infections hautes de l’appareil urinaire. La revue du praticien, n° :9, 1993.
[78] Flam T.: Infection urinaire Hôpital Cochin Paris- Service d’urologie- France
1999.
100
[82] Gauzit R.; Nathan C.; Pourriat Jl.: Infections urinaires périopératoires,
Encycl Méd Chir, Anesth-Réanim, 2002.
[83] Martine Bl.; Botto H.: Infections urinaires nosocomiales, Formation
médicale continue, Progrès en Urologie; 1997.
[84] Flandrois J.P.; Chomarat M.: L’examen cytobactériologique des urines, In
Bacteriologie médicale pratique, MEDSI/MC GRAW-HILL, Paris 1988.
[85] Amarenco G.; Kerdraon J.: Vessies neurologiques. EMC (Elsevier SAS,
Paris), Neurologie, 17-012-L-10, 2006.
[86] Nour C.: Germes urinaires et leurs résistances, Thèse de pharmacie ; Faculté
de Médecine et de Pharmacie de Rabat, Université Mohammed V ; 2004.
[87]
https://www.infectiologie.com/UserFiles/File/formation/ecn-pilly-2018/ecn-2018-ue6-157-nb.pdf.
[88] Pappas P. Laboratory in the diagnosis and management of urinary tract
infections. Medical Clinics of North America 1991; 75:313-25.
[89] Wilson M, Gaido L. Laboratory diagnosis of urniary tract infections in adult
patients. Clinical Infectious Diseases 2004; 38:1150-60.
[90] An update on uncomplicated urinary tract infection in women. Curr Opin
Urol 19:368– 374.
[91] What is the recommended workup for a man with a first UTI? JFP August 2007 (Vol. 56, No. 8).
[92] Sobel JD, Kaye D. Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Doublas, and Bennett’s Principles and Practice of Infectious Diseases. Vol II. 5th ed. Philadelphia: Churchill Livingstone; 2000:773-805.
[93] Zelenitsky SA, Zhanel GG. Phenazopyridine in urinary tract infections. Ann Pharmacother 1996;30:866-868.
[94] Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of
Vaccinum macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998;159:559-562.
[95] Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 2002;287:3082-3083.
[96] Howell AB, Vorsa N, Der Marderosian A et coll. Inhibition of the
adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998;339:1085-1086.
[97] Zafriri D, Ofek I, Adar R et coll. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989;33:92-98.
[98] Jepson RG, Mihaljevic L, Craig J. Cranberries for treating urinary tract infections. Cochrane Database Syst Rev 2000;2.
[99] Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract
infections. Cochrane Database Syst Rev 2001;3.
102
[102] Jones RN, Kugler KC, Pfaller MA et coll. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 1999;35:55-63.
[103] Pharmactuel Vol. 36 No 5 Octobre-Novembre-Décembre 2003.
[104] Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs 1997;53:583-592.
[105] Winberg J, Andersen HJ, Bergstrom T et coll. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr Scand Suppl 1974;252:1- 20.
[106] Brumfitt W. The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney Int Suppl 1975;Suppl 4:S113-119.
[107] McGrady GA, Daling JR, Peterson DR. Maternal urinary tract infection and adverse fetal outcomes. Am J Epidemiol 1985;121:377-381.
[108] Romero R, Oyarzun E, Mazor M et coll. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989;73:576-582.
[109] ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999; 56:1839-1888.
[110] Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol 1999;17:410-414.
[111] Gubbins PO, McConnell SA, Penzak SR. Current management of funguria. Am J Health Syst Pharm 1999;56:1929-1935.
[113] File:///C:/Users/pc/Downloads/P-66-2016%20(1).pdf.
[114] 1. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-3.
[115] Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992;1:281-7. [116] Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions
in diabetic patients. Diabetes Med 1997;14(1):29-34.
[117] Balasoiu D, Van Kessel KC, Van Kats-Renaud HJ, etal.Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 1997; 20(3):392-5.
[118] Andy I.M. Hoepelman, Meiland R, Suzanne, GeerlingsE. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus; International Journal of Antimicrobial Agents (2003) 22 S35-S43.
[119] Luster AD. Chemokines/chemotactic cytokines that mediateinflammation. N Engl J Med 1998;338(7):436/45.
[120] Geerlings SE, Meiland R, Van Lith EC, et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than
104
[122] Maaroufi. A. Infection Urinaire Chez Le diabetique:Epidemiologie Et Profil De Sensibilite des BacteriesIsolees Aux Antibiotiques ; thèse en médecine Faculté de médecine et pharmacie de Rabat ; Université Mohammed V ; 2009. [123] Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic
urinary tract infection in women with diabetes mellitus.Diabetes Care 2000; 23(12):1737-41.
[124] SE Geerlings, Stolk RP, Camps MJL, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care 2000; 23(6): 744-9.
[125] SE Geerlings, Brouwer EC, Gaastra W, et al. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli : studies with urine from diabetic and non-diabetic individuals J Med Microbiol 1999;48(6):535-9. [126] Hsu Hsu CY. The clinical impact of bacteremia in complicated acute
pyelonephritis. Am J Med Sci. 2006;4:175-80.
[127] Forland M, Thomas V, Shelokov A. Urinary tract infections in patients with diabetes mellitus.Studies on antibody coating of bacteria. JAMA 1997;238(18):1924-6.
[128] Forland M, Thomas VL. The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 2000;8(5):499-506.
[129] Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997;11(3):735-50.
[130] Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis ClinNorth Am 2001;15(2):407-21.
[131] Saiki J, Vaziri ND, Barton C. Perinephric and intranephricabscesses: a review of the literature. Western J Med 2002;136(2):95-102.
[132] Wheat LJ. Infection and diabetes mellitus. Diabetes Care 2000;3(1):187-97. [133] Infections Urinaires : fréquence accrue en cas de diabète. Diabète toi et moi,
https://diabete-toi-et-moi.com/infections-urinaires-diabetes/ (2018, accessed 26 February 2020).
[134] Meditcentre.fr/portail/gallery_files/site/136/2953/4197/4674/8369/8505.pdf. [135] Scandinavian Journal of Urology and Nephrology,2006;40:332-338.